The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies
Official Title: A Phase I, Open-Label Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies
Study ID: NCT00710515
Brief Summary: The purpose of this study is to test if the levels of AZD6244 in blood are affected by taking food at the same time as the capsules compared to taking capsules on an empty stomach
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Amsterdam, , Netherlands
Research Site, Maastricht, , Netherlands
Research Site, Glasgow, , United Kingdom
Research Site, Headington, , United Kingdom
Research Site, London, , United Kingdom
Research Site, Oxford, , United Kingdom
Name: Rajesh Chopra
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Name: Jan Schellens
Affiliation: Maastricht
Role: PRINCIPAL_INVESTIGATOR